The Model and Effect Assessment of Training General Practitioner for Dementia Early Recognition

December 24, 2017 updated by: Xiaozhen LV, Peking University Sixth Hospital
With the number of aged people increasing and the lifespan lengthen, dementia is becoming a great public challenge in China. Early recognition of dementia is crucial to improve the prognosis of dementia patients and decrease the society disease burden. It is a pity that the early recognition rate of dementia is less than 7% in China. Most of the aged people live in the community and general practitioners (GP) in community provide health service much more frequently than other medical workers. It is suggested that GPs should be the best one to screen dementia in its early period. However, most of GPs have not receive any training about dementia early recognition in China. It is imperative and meaningful to provide training to GPs for improve GPs' knowledge and skills about dementia early recognition. How to train GPs for early recognizing dementia and how about the training effect? Which training model may be better? We did not find consistent conclusion about these questions in China. This study aims to set up an effective and convenient model to training GPs in dementia early recognition. A total of 152 GPs in Beijing will be enrolled and be randomly divided into two groups. One group will firstly have lessons about dementia early recognition and then receive face-to-face supervision and key messages by Wechat about dementia early recognition once a month in the following 6 months. Another group will firstly have lessons about dementia early recognition and then receive face-to-face supervision and key messages by Wechat about dementia early recognition once a month in the following 3 months. The score of knowledge and attitude about dementia early recognition, the accuracy of analyzing dementia cases, the usage of dementia screening scales and the referral rate of dementia will be evaluated at different time point respectively. This study will provide evidence for training GPs effectively in dementia early recognition in the future and will promote dementia early recognition in community.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

162

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • General practitioner on-the-job and providing outpatient service
  • Can complete the intervention and questionnaire;
  • Providing informed consent voluntarily.

Exclusion Criteria:

  • General practitioner who may take a long-term vacation during the study
  • Providing less than once outpatient service every week;
  • Having no condition to use Wechat;
  • Refuse to join in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Long-term supervision group
Firstly, this group will having lessons about dementia early recognition. Second, this group will receive face-to-face supervision and key messages by Wechat about dementia early recognition once a month in the following 6 months.
Other: lessons,long-term supervision and message
Active Comparator: Short-term supervision group
Firstly, this group will having lessons about dementia early recognition. Second, this group will receive face-to-face supervision and key messages by Wechat about dementia early recognition once a month in the following 3 months.
Other: lessons,short-term supervision and message

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Difference between the change of the score of knowledge about dementia early recognition from baseline to 7th month in the experimental group and that from baseline to 4th month in the active comparator group.
Time Frame: up to 7 months
up to 7 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Difference between the change of the score of attitude about dementia early recognition from baseline to 7th month in the experimental group and that from baseline to 4th month in the active comparator group.
Time Frame: up to 7 months
up to 7 months
Difference between the change of the accurate rate of analyzing dementia case from baseline to 7th month in the experimental group and that from baseline to 4th month in the active comparator group.
Time Frame: up to 7 months
up to 7 months
Difference between the number of the elderly screened by each general practitioner per month through the study in the experimental group and that in the active comparator group.
Time Frame: up to 7 months
up to 7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Peking University Sixth Hospital

Investigators

  • Principal Investigator: Xiaozhen LV, PhD, Peking University Six Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 12, 2016

Primary Completion (Actual)

March 22, 2017

Study Completion (Actual)

July 18, 2017

Study Registration Dates

First Submitted

May 18, 2016

First Submitted That Met QC Criteria

May 20, 2016

First Posted (Estimate)

May 25, 2016

Study Record Updates

Last Update Posted (Actual)

December 27, 2017

Last Update Submitted That Met QC Criteria

December 24, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SF2016-4-4116

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on lessons,long-term supervision and message

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe